Physician

Brian Joseph Sprandio, M.D.

According to 2025 Medicare claims, Brian Sprandio, M.D. (NPI: 1356729503) practices hospice and palliative care in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Delaware, PA. This provider's primary affiliated billing organization is CONSULTANTS IN MEDICAL ONCOLOGY & HEMATOLOGY, PC (NPI: 1043265820; TIN: 23-2826618) and primary practice location at 19008-3301. Sprandio is affiliated with the Delaware Valley ACO (ACO ID: A2024), participating under the MSSP model.

Sprandio's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 201 traditional Medicare patients, billed 1,158 HCPCS/CPT codes, and received $66,057 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 808 prescription claims across 174 beneficiaries totaling $29,663 in drug costs, led by Oxycontin (Oxycodone Hcl). 2021 DME data shows 12 claims. Open Payments data shows 121 records totaling $2,861. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $17,380 to $66,057. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,523 and ending at $29,663. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	93	157	$17,380
2020	220	454	$43,257
2021	211	2,822	$82,346
2022	196	3,849	$157,719
2023	227	2,000	$92,877
2024	201	1,158	$66,057

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	21	49	$1,523
2016	88	407	$20,089
2017	91	402	$49,627
2018	58	281	$25,199
2019	13	41	$4,855
2020	22	148	$10,953
2021	65	214	$10,561
2022	128	614	$20,951
2023	150	729	$23,187
2024	174	808	$29,663

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	11	$135
2021	N/R	12	$159
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	86	90	$135
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	103	242	$102
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	103	273	$73
99497	Advance care planning, first 30 minutes	68	93	$63
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	11	11	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycontin	Oxycodone Hcl	13	286	$7,468
Mirtazapine	Mirtazapine	65	5,294	$2,601
Duloxetine Hcl	Duloxetine Hcl	74	5,263	$1,765
Gabapentin	Gabapentin	111	5,284	$1,296
Oxycodone Hcl	Oxycodone Hcl	84	1,679	$899

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	121	$2,861	SHIELD THERAPEUTICS INC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian Joseph Sprandio, M.D.?

Tedicare shows public-source Medicare data for Brian Joseph Sprandio, M.D. (NPI 1356729503), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian Joseph Sprandio, M.D. have ACO affiliation data?

Brian Joseph Sprandio, M.D. is shown with ACO affiliation data for Delaware Valley ACO (MSSP, ACO ID A2024).

What billing organization is linked to Brian Joseph Sprandio, M.D.?

Brian Joseph Sprandio, M.D. is linked to CONSULTANTS IN MEDICAL ONCOLOGY & HEMATOLOGY, PC (billing NPI 1043265820) in the available physician profile data.

Does Brian Joseph Sprandio, M.D. have Open Payments data?

Brian Joseph Sprandio, M.D. has 121 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.